This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Aspirin/meprobamate" – news · newspapers · books · scholar · JSTOR (June 2016) (Learn how and when to remove this template message)
Aspirin/meprobamate
Combination of
AspirinNSAID
MeprobamateAnxiolytic
Clinical data
Trade namesEquagesic
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration		Oral
ATC code
Legal status
Legal status
Identifiers
CAS Number

Aspirin/meprobamate (trade name Equagesic /ˌɛkwəˈdʒiːzɪk/) is a combination drug indicated for short-term pain treatment accompanied by tension or anxiety in patients with musculoskeletal disorders or tension headache.

Adverse effects

See also: Aspirin § Adverse effects, and Meprobamate § Adverse effects

Combinations

There also appears to be a combination with ethoheptazine, an opioid analgesic.[1]

Problems

Equagesic was discontinued in the United States, because of its possible toxic effects, specifically of meprobamate.[2][medical citation needed] It was credited with the sudden death of actor Bruce Lee in 1973. Lee suffered a fatal hypersensitive reaction to one of the prescription drug's ingredients while working in Hong Kong.[3][4]

References

  1. ^ "Equagesic". NetDoctor.co.uk. Archived from the original on 27 September 2007. Discontinued in the UK – March 2002
  2. ^ "Meprobamate Tablets 400mg – Summary of Product Characteristics (SmPC) – (emc)". www.medicines.org.uk. Retrieved 2021-08-09.
  3. ^ Chang R (7 June 2020). "Bruce Lee: The Mystery Surrounding the Martial Artist's Death". Biography. Retrieved 2021-08-09.
  4. ^ "Bruce Lee". Bruce Lee. Retrieved 2021-08-09.


Categories